LARIMAR THERAPEUTICS, INC. Operating Expenses
LARIMAR THERAPEUTICS, INC. (LRMR) reported Operating Expenses of $34.35 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-04
- LARIMAR THERAPEUTICS, INC. operating expenses for the quarter ending 2026-06-30 was $34.35M, a 23.60% increase year-over-year.
- LARIMAR THERAPEUTICS, INC. operating expenses for the quarter ending 2026-03-31 was $31.12M, a 0.23% decline year-over-year.
- LARIMAR THERAPEUTICS, INC. operating expenses for the quarter ending 2025-12-31 was $64.02M, a 104.58% increase year-over-year.
- LARIMAR THERAPEUTICS, INC. operating expenses for the quarter ending 2025-09-30 was $49.50M, a 171.02% increase year-over-year.
- LARIMAR THERAPEUTICS, INC. operating expenses for fiscal 2025 was $172.50M, a 89.79% increase from fiscal 2024.
- LARIMAR THERAPEUTICS, INC. operating expenses for fiscal 2024 was $90.89M, a 117.66% increase from fiscal 2023.
- LARIMAR THERAPEUTICS, INC. operating expenses for fiscal 2023 was $41.76M, a 14.32% increase from fiscal 2022.
- LARIMAR THERAPEUTICS, INC. operating expenses for fiscal 2022 was $36.53M, a 27.62% decline from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $34.35M 10-Q · filed 2026-08-04 | $65.47M 10-Q · filed 2026-08-04 | $129.49M derived: sum of 3 quarters · filed 2026-08-04 | $178.99M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $31.12M 10-Q · filed 2026-05-14 | $95.14M derived: sum of 2 quarters · filed 2026-05-14 | $144.63M derived: sum of 3 quarters · filed 2026-05-14 | $172.43M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $64.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $113.52M derived: sum of 2 quarters · filed 2026-03-19 | $141.31M derived: sum of 3 quarters · filed 2026-08-04 | $172.50M 10-K · filed 2026-03-19 | ||||
| 2025-09-30 | $49.50M 10-Q · filed 2025-11-05 | $77.29M derived: sum of 2 quarters · filed 2026-08-04 | $108.48M 10-Q · filed 2025-11-05 | $139.77M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $27.79M 10-Q · filed 2026-08-04 | $58.98M 10-Q · filed 2026-08-04 | $90.27M derived: sum of 3 quarters · filed 2026-08-04 | $108.54M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $31.19M 10-Q · filed 2026-05-14 | $62.48M derived: sum of 2 quarters · filed 2026-05-14 | $80.75M derived: sum of 3 quarters · filed 2026-05-14 | $105.34M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | $31.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $49.56M derived: sum of 2 quarters · filed 2026-03-19 | $74.16M derived: sum of 3 quarters · filed 2026-03-19 | $90.89M 10-K · filed 2026-03-19 | ||||
| 2024-09-30 | $18.26M 10-Q · filed 2025-11-05 | $42.86M derived: sum of 2 quarters · filed 2025-11-05 | $59.60M 10-Q · filed 2025-11-05 | $73.76M derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-30 | $24.60M 10-Q · filed 2025-08-14 | $41.33M 10-Q · filed 2025-08-14 | $55.49M derived: sum of 3 quarters · filed 2025-08-14 | $65.83M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $16.73M 10-Q · filed 2025-04-30 | $30.90M derived: sum of 2 quarters · filed 2025-04-30 | $41.23M derived: sum of 3 quarters · filed 2025-04-30 | $50.85M derived: sum of 4 quarters · filed 2025-04-30 | ||||
| 2023-12-31 | $14.16M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $24.50M derived: sum of 2 quarters · filed 2025-03-24 | $34.12M derived: sum of 3 quarters · filed 2025-03-24 | $41.76M 10-K · filed 2025-03-24 | ||||
| 2023-09-30 | $10.34M 10-Q · filed 2024-10-30 | $19.96M derived: sum of 2 quarters · filed 2024-10-30 | $27.60M 10-Q · filed 2024-10-30 | $38.03M derived: sum of 4 quarters · filed 2024-10-30 | ||||
| 2023-06-30 | $9.62M 10-Q · filed 2024-08-08 | $17.26M 10-Q · filed 2024-08-08 | $27.70M derived: sum of 3 quarters · filed 2024-08-08 | $36.21M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $7.64M 10-Q · filed 2024-05-09 | $18.08M derived: sum of 2 quarters · filed 2024-05-09 | $26.59M derived: sum of 3 quarters · filed 2024-05-09 | $35.28M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $10.44M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $18.95M derived: sum of 2 quarters · filed 2024-03-14 | $27.64M derived: sum of 3 quarters · filed 2024-03-14 | $36.53M 10-K · filed 2024-03-14 | ||||
| 2022-09-30 | $8.51M 10-Q · filed 2023-11-14 | $17.20M derived: sum of 2 quarters · filed 2023-11-14 | $26.09M 10-Q · filed 2023-11-14 | $35.17M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $8.69M 10-Q · filed 2023-08-10 | $17.57M 10-Q · filed 2023-08-10 | $26.66M derived: sum of 3 quarters · filed 2023-08-10 | $43.39M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $8.89M 10-Q · filed 2023-05-15 | $17.97M derived: sum of 2 quarters · filed 2023-05-15 | $34.70M derived: sum of 3 quarters · filed 2023-05-15 | $47.25M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $9.09M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $25.82M derived: sum of 2 quarters · filed 2023-03-14 | $38.36M derived: sum of 3 quarters · filed 2023-03-14 | $50.47M 10-K · filed 2023-03-14 | ||||
| 2021-09-30 | $16.73M 10-Q · filed 2022-11-10 | $29.27M derived: sum of 2 quarters · filed 2022-11-10 | $41.38M 10-Q · filed 2022-11-10 | $55.77M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $12.54M 10-Q · filed 2022-08-11 | $24.65M 10-Q · filed 2022-08-11 | $39.05M derived: sum of 3 quarters · filed 2022-08-11 | $49.38M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $12.11M 10-Q · filed 2022-05-12 | $26.50M derived: sum of 2 quarters · filed 2022-05-12 | $36.84M derived: sum of 3 quarters · filed 2022-05-12 | $48.24M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $14.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $24.73M derived: sum of 2 quarters · filed 2022-03-25 | $36.13M derived: sum of 3 quarters · filed 2022-03-25 | $42.80M 10-K · filed 2022-03-25 | ||||
| 2020-09-30 | $10.34M 10-Q · filed 2021-11-12 | $21.73M derived: sum of 2 quarters · filed 2021-11-12 | $28.41M 10-Q · filed 2021-11-12 | $35.69M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | $11.40M 10-Q · filed 2021-08-12 | $18.07M 10-Q · filed 2021-08-12 | $25.35M derived: sum of 3 quarters · filed 2021-08-12 | $33.98M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $6.67M 10-Q · filed 2021-05-10 | $3.56M 10-Q · filed 2020-05-07 | $13.96M derived: sum of 2 quarters · filed 2021-05-10 | $22.58M derived: sum of 3 quarters · filed 2021-05-10 | $26.29M derived: sum of 4 quarters · filed 2021-05-10 | |||
| 2019-12-31 | $7.28M 10-K · filed 2020-03-05 | $15.91M derived: sum of 2 quarters · filed 2020-11-12 | $19.61M derived: sum of 3 quarters · filed 2020-11-12 | $23.21M 10-K · filed 2021-03-04 | $45.65M 10-K · filed 2020-03-05 | |||
| 2019-09-30 | $8.63M 10-Q · filed 2020-11-12 | $12.91M 10-Q · filed 2019-11-06 | $12.33M derived: sum of 2 quarters · filed 2020-11-12 | $17.06M 10-Q · filed 2020-11-12 | $38.37M 10-Q · filed 2019-11-06 | $40.30M derived: sum of 4 quarters · filed 2020-11-12 | ||
| 2019-06-30 | $3.70M 10-Q · filed 2020-08-14 | $12.19M 10-Q · filed 2019-08-08 | $8.43M 10-Q · filed 2020-08-14 | $25.47M 10-Q · filed 2019-08-08 | $31.67M derived: sum of 3 quarters · filed 2020-08-14 | $46.84M derived: sum of 4 quarters · filed 2020-08-14 | ||
| 2019-03-31 | $13.28M 10-Q · filed 2020-05-07 | $27.97M derived: sum of 2 quarters · filed 2020-05-07 | $43.14M derived: sum of 3 quarters · filed 2020-05-07 | $58.70M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $14.69M 10-K · filed 2020-03-05 | $29.86M derived: sum of 2 quarters · filed 2020-03-05 | $45.42M derived: sum of 3 quarters · filed 2020-03-05 | $61.12M 10-K · filed 2020-03-05 | ||||
| 2018-09-30 | $15.17M 10-K · filed 2020-03-05 | $30.73M derived: sum of 2 quarters · filed 2020-03-05 | $46.43M 10-Q · filed 2019-11-06 | $59.79M derived: sum of 4 quarters · filed 2020-03-05 | ||||
| 2018-06-30 | $15.56M 10-K · filed 2020-03-05 | $31.26M 10-Q · filed 2019-08-08 | $44.62M derived: sum of 3 quarters · filed 2020-03-05 | $57.46M derived: sum of 4 quarters · filed 2020-03-05 | ||||
| 2018-03-31 | $15.70M 10-K · filed 2020-03-05 | $29.06M derived: sum of 2 quarters · filed 2020-03-05 | $41.90M derived: sum of 3 quarters · filed 2020-03-05 | $55.44M derived: sum of 4 quarters · filed 2020-03-05 | ||||
| 2017-12-31 | $13.36M 10-K · filed 2019-03-14 | $26.20M derived: sum of 2 quarters · filed 2019-03-14 | $39.73M derived: sum of 3 quarters · filed 2019-03-14 | $53.00M 10-K · filed 2020-03-05 | ||||
| 2017-09-30 | $12.84M 10-K · filed 2019-03-14 | $26.38M derived: sum of 2 quarters · filed 2019-03-14 | $39.64M 10-Q · filed 2018-11-09 | $50.12M derived: sum of 4 quarters · filed 2019-03-14 | ||||
| 2017-06-30 | $13.54M 10-K · filed 2019-03-14 | $26.80M 10-Q · filed 2018-08-09 | $37.28M derived: sum of 3 quarters · filed 2019-03-14 | $52.11M derived: sum of 4 quarters · filed 2019-03-14 | ||||
| 2017-03-31 | $13.27M 10-Q · filed 2018-05-10 | $23.74M derived: sum of 2 quarters · filed 2019-03-14 | $38.57M derived: sum of 3 quarters · filed 2019-03-14 | $53.63M derived: sum of 4 quarters · filed 2019-03-14 | ||||
| 2016-12-31 | $10.47M 10-K · filed 2018-03-09 | $25.31M derived: sum of 2 quarters · filed 2018-03-09 | $40.37M derived: sum of 3 quarters · filed 2018-03-09 | $58.23M 10-K · filed 2019-03-14 | ||||
| 2016-09-30 | $14.83M 10-K · filed 2018-03-09 | $29.89M derived: sum of 2 quarters · filed 2018-03-09 | $47.75M 10-Q · filed 2017-11-07 | $71.00M derived: sum of 4 quarters · filed 2018-03-09 | ||||
| 2016-06-30 | $15.06M 10-K · filed 2018-03-09 | $32.92M 10-Q · filed 2017-08-09 | $56.16M derived: sum of 3 quarters · filed 2018-03-09 | $75.88M derived: sum of 4 quarters · filed 2018-03-09 | ||||
| 2016-03-31 | $17.86M 10-K · filed 2018-03-09 | $41.10M derived: sum of 2 quarters · filed 2018-03-09 | $60.82M derived: sum of 3 quarters · filed 2018-03-09 | $78.43M derived: sum of 4 quarters · filed 2018-03-09 | ||||
| 2015-12-31 | $23.25M 10-K · filed 2017-03-10 | $42.96M derived: sum of 2 quarters · filed 2017-03-10 | $60.57M derived: sum of 3 quarters · filed 2017-03-10 | $73.81M 10-K · filed 2018-03-09 | ||||
| 2015-09-30 | $19.72M 10-K · filed 2017-03-10 | $37.33M derived: sum of 2 quarters · filed 2017-03-10 | $50.57M 10-Q · filed 2016-11-09 | $61.23M derived: sum of 4 quarters · filed 2017-03-10 | ||||
| 2015-06-30 | $17.61M 10-K · filed 2017-03-10 | $30.85M 10-Q · filed 2016-08-05 | $41.51M derived: sum of 3 quarters · filed 2017-03-10 | $55.88M derived: sum of 4 quarters · filed 2017-03-10 | ||||
| 2015-03-31 | $13.24M 10-K · filed 2017-03-10 | $23.90M derived: sum of 2 quarters · filed 2017-03-10 | $38.27M derived: sum of 3 quarters · filed 2017-03-10 | $44.25M derived: sum of 4 quarters · filed 2017-03-10 | ||||
| 2014-12-31 | $10.66M 10-K · filed 2016-03-15 | $25.02M derived: sum of 2 quarters · filed 2016-03-15 | $31.01M derived: sum of 3 quarters · filed 2016-03-15 | $35.53M 10-K · filed 2017-03-10 | ||||
| 2014-09-30 | $14.36M 10-K · filed 2016-03-15 | $20.35M derived: sum of 2 quarters · filed 2016-03-15 | $24.87M 10-Q · filed 2015-11-13 | $28.63M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2014-06-30 | $5.99M 10-K · filed 2016-03-15 | $10.51M 10-Q · filed 2015-08-14 | $14.27M derived: sum of 3 quarters · filed 2016-03-15 | $17.79M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2014-03-31 | $4.52M 10-K · filed 2016-03-15 | $8.28M derived: sum of 2 quarters · filed 2016-03-15 | $11.81M derived: sum of 3 quarters · filed 2016-03-15 | $14.78M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2013-12-31 | $3.76M 10-K · filed 2015-03-25 | $7.29M derived: sum of 2 quarters · filed 2015-03-25 | $10.26M derived: sum of 3 quarters · filed 2015-03-25 | $13.78M 10-K · filed 2016-03-15 | ||||
| 2013-09-30 | $3.52M 10-K · filed 2015-03-25 | $6.50M derived: sum of 2 quarters · filed 2015-03-25 | $10.02M 10-Q · filed 2014-11-13 | |||||
| 2013-06-30 | $2.98M 10-K · filed 2015-03-25 | $6.50M 10-Q · filed 2014-08-14 | ||||||
| 2013-03-31 | $3.52M 10-K · filed 2015-03-25 | |||||||
| 2012-12-31 | $13.79M 10-K · filed 2015-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |